There should be no rush to replay Hipgnosis’s noisy stock market experiment

There should be no rush to replay Hipgnosis’s noisy stock market experiment

The sale of the music fund ends its tumultuous years as a listed company – and that may be for the best, for it and its investors

So ends a stock market experiment that is unlikely to be repeated in a hurry: Hipgnosis Songs Fund, the music royalties company with songs by the likes of Beyoncé, Blondie and Chic, is to be sold to a US fund for less than its starting price in 2018 of 100p.

The immediate point is that 93p a share, or £1.1bn, is a lot better than shareholders were looking at in recent months. The price went as low as 60p during the company’s bust-up with its own investment adviser, a suspension of dividends (unforgivable for a fund designed to turn royalties into income) and a writedown in the value of assets after a tortuous debate about valuation methodologies.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *